Synbio Technologies aims to become the most trusted provider of DNA solutions that empowers scientific discoveries by providing highly-accurate and cost-effective synthetic biology services and products for researchers around the world.
Founded in 2013 by a group of passionate synthetic biologists with decades of industry experience and a proven track record of delivering cost-effective DNA solutions, Synbio Technologies is incorporated with a single mission in mind: empower scientific discoveries by providing access to the world’s most advanced synthetic biology tools and services. Its dedicated team of experts and progressive DNA technologies enable researchers, scientists, synthetic biologists, and drug developers to push the boundaries of what is possible in the life sciences.
Synbio Technologies have developed a full range of DNA reading (sequencing), DNA writing (synthesis), and DNA editing (engineering) capabilities for various applications, including diagnostic DNA probes, precision medicine, protein production, antibody discovery, vaccine development, novel enzymes, molecular breeding, biofuel implication, and more.
Nucleus Biotech is pleased to represent Synbio Technologies´scientific capabilities covering all facets of DNA synthesis and engineering, offering a full range of support for molecular biology work, including but not limited to:
- Oligo synthesis
- Gene synthesis
- Subcloning & PCR cloning
- Plasmid preparation (up to gram scale)
- DNA variant libraries (Permutation, random, trimer libraries, etc.)
- CRISPR sgRNA
- Protein expression and purification in multiple systems (E.coli, yeast, and mammalian cells)